How to Buy Repare Therapeutics Stock
Repare Therapeutics Inc
Repare Therapeutics Inc. , a clinical-stage precision oncology company, discovers and develops therapeutics by using its synthetic lethality approach in Canada and the United States.
Repare Therapeutics stock last closed at $1.37, up 14.17% from the previous day, and has decreased 57.98% in one year. It has overperformed other stocks in the Biotechnology industry by 0.19 percentage points. Repare Therapeutics stock is currently +53.93% from its 52-week low of $0.89, and -68.07% from its 52-week high of $4.29.
At the moment, there are 42.51M shares of RPTX outstanding. The market value of RPTX is $58.24M. In the last 24 hours, 935,214 RPTX shares were traded.
How to Buy Repare Therapeutics Stock
Wondering how to invest in Repare Therapeutics stock? Here's how.
- Choose where to buy Repare Therapeutics stock: You need to choose an online brokerage, but don't worry - we've analyzed dozens of stock brokerages and apps to help you choose where to buy Repare Therapeutics stock.
- Open your brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've selected.
- Put funds into your brokerage account: Pick your payment method and add your details.
- Evaluate Repare Therapeutics stock: The Repare Therapeutics ticker symbol is RPTX. Is Repare Therapeutics stock a good investment? Should you buy shares of RPTX? How do RPTX's underlying business fundamentals look? Do top analysts think Repare Therapeutics is a good buy? Why has RPTX's stock price moved recently? (Hint: Our stock market research website can help you understand if RPTX is a good stock to buy).
- Make your RPTX purchase: Decide if you will purchase RPTX shares at the current market price or use a limit order to buy RPTX stock at a given price.
- Get notifications regarding your RPTX investment: Create a watchlist to the latest updates on your new investment in Repare Therapeutics shares.
Step 1: Choose where to buy Repare Therapeutics stock
You need an online brokerage account in order to access the NASDAQ market and buy RPTX stock.
Our preferred brokerage: eToro
Based on our experience, eToro is the best place to buy stocks. Here's why:
- You can invest in stocks with zero commissions: Invest without commissions.
- Buy fractional shares: Even if you can't afford a full share, you can still buy the stock.
- Access to global markets: From Technology to Real Estate, New York to Hong Kong (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's leading exchanges.
- Social investing: eToro boasts a community with more than 20 million users worldwide. Talk to, learn from, and copy the crypto trades of other investors.
- Security: eToro is a regulated and licensed fintech leader.
- Buy other financial assets: Such as ETFs and cryptocurrencies.
Get $10 towards your share purchase by opening an account with eToro now. This offer is only for US users.
Open eToro AccountStep 2: Open your brokerage account
Now that you've chosen the best brokerage, you'll need to fill out some personal details so you are able to buy RPTX today.
How to Create a New Investment Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Input your personal data to start a new brokerage account.
- Send your info by hitting the "Create Account" button. Get started with eToro today
Step 3: Put funds into your brokerage account
Now that you've opened your account on our top ranked stock app, your next step is to transfer the money for your investment:
Watch the video below if you need help transferring funds into your new investment account.
Step 4: Evaluate Repare Therapeutics stock
Once you have chosen the best place to buy Repare Therapeutics stock, it's critical to research their stock prior to investing, so you can comprehend the risk and upside.
Repare Therapeutics stock data
Repare Therapeutics Due Diligence Score
WallStreetZen was designed to help everyday investors perform more accurate fundamental analysis quickly.
You can see all of the due diligence checks on RPTX's stock page.
Is RPTX stock properly valued?
Analysts use a variety of different financial metrics, analyses, models, and charts to gauge RPTX's true value.
Using relative valuations measures:
- RPTX may be undervalued based on its P/B ratio of 0.39x, relative to Biotechnology industry P/B ratio of 4.16x
You can access additional valuation research on RPTX's stock here.
How do RPTX Financials look?
Positive Financial Indicators:
- RPTX has cash burn of 76445000. It has enough cash and short-term investments to cover this for at least one year.
- RPTX has a low debt to equity ratio of 0.17.
- There are more short-term assets than long-term liabilities on the RPTX balance sheet.
- There are more short-term assets than short-term liabilities on the RPTX balance sheet.
- Total RPTX debt is lower than 5 years ago, relative to shareholder equity.
- RPTX has $152.79M in cash and short term investments. This is enough to cover its annual cash burn of $76.45M.
Negative Financial Indicators:
- RPTX profit margin has gone up by 0.25 percentage points in the past year, but the company is still unprofitable.
Is it a good time to buy RPTX stock, according to analysts?
Out of 2 Wall Street analysts who give ratings on RPTX, the consensus analyst rating on RPTX is a Strong Buy
It's important to keep in mind that analyst ratings are not stock recommendations, nor are they financial advice.
You can dig deeper into what analysts are saying on the Repare Therapeutics stock forecast page.
RPTX Trading Indicators
RPTX Earnings
Last year, RPTX revenue was $53.48M. During the last 4 year, RPTX's revenue has gone up by 346.13% per year. This was faster than the Biotechnology industry average of 44.4%.
Dig into RPTX's earnings and revenue performance here.
Are RPTX insiders buying or selling the stock?
Over the past 12 months, insiders at RPTX have sold more shares than they have bought.
Steve Forte, EVP CHIEF FINANCIAL OFFICER of RPTX, was the latest RPTX insider to sell. They sold $7,847.76 worth of RPTX stock on Mar 12, 2025.
Get more info about who owns RPTX stock here.
Does RPTX provide a stable income stream?
No, Repare Therapeutics doesn't provide an income stream by paying out dividends.
What do other traders have to say about RPTX?
One of the major reasons eToro is our favorite brokerage is because of its social trading community.
Click below to see what other investors have to say.
Step 5: Make your RPTX purchase
There are two main types of orders:
- Market order: A market order is an order to buy or sell a security at the best possible price.
Market orders are mostly fine. - Limit order: A limit order enables you to buy or sell a stock at a specific price (or better).
If you want to be sure you're buying or selling at a given dollar amount limit, use a limit order.
Press the Open Trade button and eToro will execute the order.
If you require more help investing in stocks on eToro, watch the helpful video below:
Step 6: Get notifications regarding your RPTX investment
Now that you own some shares in RPTX, you'll want to keep up with your new investment.
Put RPTX on a watchlist to see the latest developments about your RPTX stock.
RPTX Feed
How to Buy Stock in Repare Therapeutics
To reiterate, here are the 6 steps to buy Repare Therapeutics stock:
- Choose where to buy Repare Therapeutics stock
- Open your brokerage account
- Put funds into your brokerage account
- Evaluate Repare Therapeutics stock
- Make your RPTX purchase
- Get notifications regarding your RPTX investment
If you need a brokerage, eToro is our favorite option.
Get Started with eToro TodayIf you want to get the latest news on your investment in Repare Therapeutics, create your watchlist below.
Trending Articles
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.